In this episode of the DeviceTalks Weekly Podcast, we’ll talk with Intuitive Surgical’s Julian Nikolchev, senior vice president, corporate development and strategy, and Dr. Oliver Keown, director of Intuitive Ventures, about the new $100 million venture fund. How will the capital be invested? Where does Intuitive see the opportunity, and how does the program fit […]
Masimo
The top 5 MassDevice stories of the week — November 6, 2020
The medical device industry continues to move along — with M&A deals made and earnings reported — even as many people focus on the U.S. presidential election. Want to hear more about the week’s top news? Executive editor Chris Newmarker and Tom Salemi will discuss the week’s “Newmarker’s Newsmakers” — as well as fictional monsters […]
Masimo to acquire Lidco for $40.1M
Masimo (NSDQ:MASI) today confirmed that it is set to acquire advanced hemodynamic monitoring device maker Lidco for approximately $40.1 million. Both companies’ boards confirmed in an announcement that they agreed on the terms of a recommended cash offer to be made by Masimo for the entire issued and to be issued share capital of Lidco, totaling […]
How much is COVID-19 affecting procedure volumes for medtech?
UBS Financial Services released a report detailing how it expects medtech procedures to potentially keep dipping during the COVID-19 pandemic. The report highlighted a quicker-than-expected recovery in the second quarter after U.S. hospitals began canceling, delaying and deferring elective procedures in late March as the pandemic took hold. However, UBS still expects third-quarter medical procedures […]
FDA clears Masimo’s Rad-G pulse oximeter
Masimo (NSDQ:MASI) said today that FDA has granted a 510(k) clearance for its rugged handheld Rad-G pulse oximeter. The Rad-G provides clinically proven SET pulse oximetry, respiration rate from the pleth (RRp), and other vital parameters for both spot-checking and continuous monitoring, according to Masimo. Other product descriptions and claims from Masimo include a long-lasting rechargeable […]
FDA clears Masimo oximetry device
Masimo this week announced that its O3 Regional Oximetry received expanded FDA clearance. The expanded use covers monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin and deoxyhemoglobin in adult brains. O3 is also now indicated for use in both cerebral and somatic applications. The oximetry device uses […]
FDA clears Masimo index to better track ventilated patients
Masimo (NSDQ:MASI) announced today that it received FDA clearance for its PVi for fluid responsiveness indication in ventilated adult patients. PVi (pleth variability index) now has indication as a continuous, non-invasive, dynamic indicator of responsiveness in select populations of mechanically ventilated adult patients, as it measures dynamic changes in the perfusion index that occur during the […]
Masimo providing pulse oximeters to monitor NBA players
Masimo (NSDQ:MASI) announced today that it entered into a partnership with the National Basketball Association to become its official supplier of pulse oximetry. The NBA is scheduled to return to competitive play tonight after going through steps to maintain safety in a “bubble”-style camp in Orlando, Fla. with 22 teams in an effort to ensure safety […]
Masimo debuts patient-info platform
Masimo (NSDQ:MASI) this week launched its UniView: 60 Hospital Automation platform. The platform aggregates and displays pertinent patient information on a display outside of a patient’s room. It allows clinicians to familiarize themselves with each patient’s case at the hospital room door in 60 seconds or less before physically seeing a patient. The information included in […]
Masimo announces drug-free opioid-withdrawal device
Masimo (NSDQ:MASI) announced that it received FDA de novo classification for its Bridge neuromodulation-based opioid withdrawal device. Bridge uses neuromodulation to aid in reducing the symptoms associated with opioid withdrawal. Irvine, Calif.-based Masimo touts it as the first evidence-based, drug-free, non-surgical device of its kind. The wearable, single-patient-use, percutaneous neurostimulator fits behind the ear and applies […]
FDA clears Masimo respiration sensor
Masimo (NSDQ:MASI) announced today that its Centroid wireless orientation, activity and respiration rate sensor received FDA clearance. Centroid is a wearable sensor designed to monitor patient position in an effort to avoid preventable pressure ulcers, while also alerting clinicians to sudden movements, such as fall-like events. The device also detects chest movements to continuously provide respiration […]
